For the Inventor, By the Inventor

Enter assignee name

Sanofi-Synthelabo

USPTO Granted Patents = 152

% Expired Patents = 27.6

CIPO Patents = 7

Trademarks = 19

Forward Citations = 2,486

Loading Chart...

Loading Chart...

342 inventors (with patents filed for the assignee):

Alistair Lochead (11 out of 75 patents)

Bertrand Castro (11 out of 14 patents)

Samir Jegham (10 out of 39 patents)

4. Xavier Emonds-Alt (9 out of 46 patents)

5. Claudine Serradeil-Le Gal (8 out of 21 patents)

6. Vincenzo Proietto (8 out of 47 patents)

7. Patrick Gueule (7 out of 32 patents)

8. Umberto Guzzi (7 out of 43 patents)

9. Marc Brunel (7 out of 9 patents)

10. Didier Van Broeck (7 out of 40 patents)

11. Pierre Casellas (6 out of 48 patents)

12. Daniel Bichon (6 out of 41 patents)

13. Jean-Robert Dormoy (6 out of 13 patents)

14. Frédéric Galli (6 out of 6 patents)

15. Marco Baroni (5 out of 34 patents)

Core Competencies:

Pharmaceutical Composition

Drug Delivery Systems

Controlled Release

Therapeutic Use

Benzimidazole Derivatives

Injection Devices

Amino Derivatives

Polysaccharides

Pyrimidone Derivatives

Antipsychotic Compounds

Synthesis Intermediates

Receptor Ligands

152 patents: Sort by Forward Citations

1. 8535721 - Pharmaceutical microspheres containing valproic acid for oral administration (2013-09-17),

2. 7427615 - 3-substituted-4-pyrimidone derivatives (2008-09-23),

3. 6979683 - Benzimidazole derivatives, preparation and therapeutic use thereof (2005-12-27),

4. 6949583 - Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same (2005-09-27),

5. 6918889 - Disposable injection device (2005-07-19),

6. 6916929 - Method for preparing 4-methylamino-4-phenylpiperidine (2005-07-12),

7. 6908927 - Pyridopyranoazepine derivatives, their preparation and their therapeutic application (2005-06-21),

8. 6908914 - Antipsychotic cyclic N-aralkylamines (2005-06-21),

9. D505320 - Packaging for a drug blister-pack for clinical trial (2005-05-24),

10. 6894186 - Hydroxyacetic ester derivatives, preparation method and use as synthesis intermediates (2005-05-17),

11. 6893659 - Pharmaceutical composition for oral administration of a N-piperidino-3- pyrazolecarboxamide derivative, its salts and their solvates (2005-05-17),

12. 6867220 - Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them (2005-03-15),

13. 6864277 - 1,3-dihydro-2H-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them (2005-03-08),

14. 6861072 - Pharmaceutical composition with gastric residence and controlled release (2005-03-01),

15. 6858629 - Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same (2005-02-22),

Company Overview

Sanofi-Synthelabo, based in Paris, France, is a prominent player in the pharmaceutical chemistry sector, focusing on the development and manufacturing of innovative drug formulations. The company specializes in pharmaceutical compositions and advanced drug delivery systems, emphasizing controlled release mechanisms and therapeutic applications. Its research spans various core technology topics, including benzimidazole and amino derivatives, as well as polysaccharides, contributing to the advancement of effective injection devices and therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

152 Patents

#51 in Paris

#188 in France

#5,376 in the World

Sanofi-Synthelabo

Forward Citations = 2,486

342 inventors:

Alistair Lochead (11 out of 75 patents)

Bertrand Castro (11 out of 14 patents)

Samir Jegham (10 out of 39 patents)

4. Xavier Emonds-Alt (9 out of 46 patents)

5. Claudine Serradeil-Le Gal (8 out of 21 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sanofi-Synthelabo. Retrieved from https://idiyas.com/company/sanofi-synthelabo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…